RESUMEN
BACKGROUND: The TANTALUS system (MetaCure Ltd.) is a minimally invasive implantable gastric stimulation modality that does not exhibit malabsorptive or restrictive characteristics. The device applies gastric contractility modulation (GCM) signals to the stomach antrum. The signals are delivered in synchronization to the native electrical activity of the stomach during meals. Retrospective analysis of previous studies indicated that type 2 diabetes mellitus (T2DM) subjects on oral medication with hemoglobin A1c (HbA1c) between 7.5% and 9.5% are the population with most potential benefit from the treatment. The current study includes subjects enrolled prospectively within that range of HbA1c. AIM: To prospectively investigate the potential effect of the TANTALUS system on glycemic control and weight in overweight subjects with T2DM. METHODS: In this European multicenter, open-label study, 13 T2DM obese (6 male, 7 female, BMI 37.2 +/- 1.0 kg/m(2), range 30.4-44.0 kg/m(2)) subjects treated with oral antidiabetic medications but with poor glycemic control (HbA1c > or = 7%, range 7.3-9.5%) were implanted laparoscopically with the TANTALUS system. RESULTS: Thirteen subjects that had completed 3 months of treatment showed a significant reduction in HbA1c from 8.0 +/- 0.2% to 6.9 +/- 0.1% (p < 0.05), whereas fasting blood glucose decreased from 175 +/- 6 mg/dL to 127 +/- 8 mg/dL (p < 0.05). The glycemic improvement was accompanied by reduction in weight from 104.4 +/- 4.4 kg to 99.7 +/- 4.8 kg, and in waist circumference from 122.3 +/- 3.2 cm to 117.0 +/- 3.0 cm. CONCLUSIONS: Interim results with the TANTALUS system suggest that this stimulation regime can potentially improve glucose levels and induce moderate weight loss in obese T2DM subjects on oral antidiabetic therapy with poor glycemic control. Further evaluation is required to determine whether this effect is due to induced weight loss and/or due to direct signal-dependent mechanisms.
Asunto(s)
Diabetes Mellitus Tipo 2/terapia , Terapia por Estimulación Eléctrica , Hemoglobina Glucada/análisis , Obesidad/terapia , Vías Aferentes/fisiología , Presión Sanguínea , Terapia Combinada , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Electrodos Implantados , Estudios de Factibilidad , Femenino , Motilidad Gastrointestinal , Humanos , Hipoglucemiantes/uso terapéutico , Laparoscopía , Masculino , Obesidad/complicaciones , Estudios Prospectivos , Antro Pilórico , Circunferencia de la CinturaRESUMEN
BACKGROUND: Bariatric surgery has increased in popularity, with Roux-en-Y Gastric Bypass (RYGB) being one of the most frequently performed. This leads to many cases in which the stomach is removed from routine gastroscopy access, sometimes being a major source of concern. Performing enteroscopy in these patients is technically difficult. We present our experience with 24 cases in which the aim was to access the detached stomach. METHODS: Retrospective analysis on RYGB enteroscopy procedures aimed to access the detached stomach. Data recorded: demographic parameters, indication, gas insufflation, time to bypass stomach, total procedure and recovery times, and endoscopic and pathological findings. RESULTS: This study included 24 patients who underwent RYGB in the previous 3-36 months. Indications were chronic abdominal pain, refractory anemia, or unexplainable weight loss. Detached stomach was accessed in 79% of patients. Access time ranged from 25 to 55 min. Recovery time for all procedures was 86.66 min on average and shorter with CO2 insufflation (42.5 min). All detached stomachs showed macroscopic gastritis; four of them were Helicobacter pylori positive. Significant findings included three patients with jejunojejunostomy stenosis and one patient with a marginal gastrojejunal ulcer, which was later diagnosed with Signet ring cell carcinoma of the proximal anastomosis. CONCLUSIONS: We present the feasibility and importance of enteroscopy of the detached stomach and believe that this procedure should be performed more frequently. A high index of suspicion is needed for postoperative symptoms in order to exclude significant pathologies and reassure symptomatic patients that there is no abnormality in the bypassed stomach.
Asunto(s)
Endoscopía Gastrointestinal/métodos , Derivación Gástrica/efectos adversos , Laparoscopía/métodos , Estómago/cirugía , Adulto , Estudios de Factibilidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios RetrospectivosRESUMEN
Translocation of enteric bacteria has been described in rats following hemorrhagic shock (HS). The aim of the present study was to evaluate the effect of hypertonic saline (HTS) on bacterial translocation (BT) in the setting of controlled HS in rats. The study included 2 arms. Arm I was a qualitative assessment of translocation. Sixty-eight anesthetized animals were studied. The rats were divided into 5 groups. Group I (n = 10) was sham shock controls. In groups II-V, HS was induced by arterial bleeding to mean arterial pressure (MAP) of 35-45 mmHg, which was maintained for 30 min. The animals were then allocated into 4 groups: group II (n = 19) untreated HS; group III (n = 13) normal saline (NS) treated; group IV (n = 13) HTS-treated; and group V (n = 13) HTS and blood treated. Mesenteric lymph nodes, liver, spleen, portal, and systemic blood were sent for culture after 24 h. Translocation occurred if enteric bacteria were cultured from at least one site. Arm II was a quantitative assessment of translocation. Two groups were studied: untreated HS (n = 7) and HTS treated (n = 6). In the qualitative arm, the 24-h mortality in untreated rats (group II) was 31.5% compared to 5.1% in treated animals (groups II-V) (P = 0.01). No BT was detected in control animals (group I). BT after HS was not different between groups II, III, and IV (92.3%, 91.6%, and 100%, respectively). Group V showed fewer translocations than groups II-IV, a difference that was especially significant compared with group IV (P = 0.039). However, BT to distant sites (systemic blood and spleen) was significantly lower in group V than in groups II-IV (P < 0.05). In the quantitative arm, the mortality rate was 16.7% in the untreated group. Although no qualitative significant difference in the translocation rate was found between the two groups (67% in untreated animals vs. 50% in HTS treated), there was significant quantitative difference: in HTS-treated group a significantly lesser bacteria translocated than in untreated animals (0.4 x 10(5) cfu/g vs. 4.2 x 10(5) cfu/g, respectively [P = 0.001]). We concluded that whereas assessed qualitatively, in this model of severe HS in rats, the hemorrhagic insult itself resulted in BT in most animals and treatment with NS, HTS, and blood resulted in reduced early mortality but did not alter significantly the translocation rate. Only the combination of HTS and blood resulted in reduced BT to distant sites. However, quantitative assessment showed that HTS significantly reduced the number of translocating bacteria.
Asunto(s)
Traslocación Bacteriana/efectos de los fármacos , Solución Salina Hipertónica/farmacología , Choque Hemorrágico/tratamiento farmacológico , Choque Séptico/prevención & control , Animales , Bacteriemia/etiología , Presión Sanguínea/efectos de los fármacos , Bacterias Gramnegativas/aislamiento & purificación , Frecuencia Cardíaca/efectos de los fármacos , Mucosa Intestinal/lesiones , Hígado/microbiología , Ganglios Linfáticos/microbiología , Masculino , Mesenterio , Vena Porta , Ratas , Ratas Sprague-Dawley , Daño por Reperfusión/microbiología , Solución Salina Hipertónica/uso terapéutico , Choque Hemorrágico/complicaciones , Choque Hemorrágico/microbiología , Choque Séptico/etiología , Bazo/microbiología , Staphylococcus aureus/aislamiento & purificación , Vasodilatación/efectos de los fármacosRESUMEN
BACKGROUND: Previous published clinical observations claim that Gastrografin, a hyperosmolar gastrointestinal water-soluble contrast agent, speeds the resolution of postoperative ileus, barium impaction ileus, adhesive small-bowel obstruction, and intestinal obstruction caused by parasites and bezoars. However, no objective data exist that support the therapeutic effects of Gastrografin in these situations. METHODS: A total of 107 episodes of adhesive, partial small-bowel obstruction in 99 patients were randomized into a control group (48 episodes), who were treated with conventional methods, and a trial group (59 episodes), who were treated with 100 ml of Gastrografin administered through the nasogastric tube. The following variables were examined: time to resolution of partial small-bowel obstruction, the need for operation, complications, and hospital stay. RESULTS: Mean timing of the first stool was 23.3 hours in the control group and 6.2 hours in the patients receiving Gastrografin (p < 0.00001). Ten obstructive episodes (21%) in the control group required operative treatment compared with six (10%) in the trial group (p = 0.12). Mean hospital stay for the patients who responded to conservative treatment was 4.4 days and 2.2 days in the control and trial groups, respectively (p < 0.00001). One patient in each group died after operation. No Gastrografin-related complications were observed. CONCLUSIONS: Orally administered Gastrografin is safe and has a therapeutic role in adhesive, partial small-bowel obstruction. It significantly prompts the resolution of the obstructive episodes and shortens hospital stay. However, further studies are necessary to confirm the significance of our observation that it may reduce the need for operation.
Asunto(s)
Diatrizoato de Meglumina/uso terapéutico , Obstrucción Intestinal/tratamiento farmacológico , Administración Oral , Anciano , Defecación , Femenino , Humanos , Obstrucción Intestinal/fisiopatología , Intestino Delgado , Tiempo de Internación , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Factores de Tiempo , Adherencias Tisulares/tratamiento farmacológico , Resultado del TratamientoRESUMEN
BACKGROUND: Upper thoracoscopic sympathectomy, obtained either by ablation or resection of the appropriate ganglia, is now the preferred treatment for primary palmar hyperhidrosis. Therefore, we undertook a review to compare the relative efficacy of these two techniques. METHODS: A Medline search was performed for the years 1974-99 to identify all published studies of thoracoscopic sympathectomy for hyperhidrosis. RESULTS: In all, 33 studies were identified and divided into two groups-ablation and resection. When the resection method was used, the immediate success rate was 99.76%, whereas the ablation method achieved dry hands in 95.2% of cases (p = 0.00001). Palmar sweating recurred in 0% of patients treated via resection and -4.4% treated with ablation. Ptosis was noted in 0.92% of cases after ablation and in 1.72% after resection (p = 0.017). CONCLUSIONS: Resection yields superior results, yet the majority of surgeons ablate, probably because it is easier, requires a shorter operating time, leads to fewer cases of Horner's syndrome, and because resympathectomy eventually overcomes initial failure.
Asunto(s)
Hiperhidrosis/cirugía , Simpatectomía/métodos , Toracoscopía/métodos , Mano , Síndrome de Horner/etiología , Síndrome de Horner/prevención & control , Humanos , Simpatectomía/efectos adversos , Toracoscopía/efectos adversosRESUMEN
BACKGROUND: Reports on intrapleural analgesia (IPA) are conflicting. The current study assessed the effect of a single-dose thoracoscopic bilateral intrapleural anesthetic administration on the immediate postoperative recovery room and 24-h pain control. METHODS: Fifty patients with primary palmar hyperhidrosis were randomly classified into two groups to receive either 20 ml of 0.5% bupivacaine and 5 mg/ml epinephrine or 0.9% NaCl in each thoracic cavity at the end of thoracoscopic T2-T3 sympathectomy. The degree of early postoperative pain was estimated by visual analog scale (VAS). The 24-h parenteral opioid analgesic requirement was recorded. RESULTS: The immediate postoperative VAS score (1.46 +/- 0.41 vs 2.0 +/- 0.61, p = 0.03), opioid consumption (0.42 +/- 0.36 vs 0.65 +/- 0.28, p = 0.0133), and 24-h opioid consumption (1.02 +/- 0.80 vs 1.48 +/- 0.84, p = 0.05) were significantly reduced following IPA compared to those of the control group. CONCLUSION: IPA is a simple and effective means for postoperative pain control following thoracoscopic upper dorsal sympathectomy.
Asunto(s)
Analgesia/métodos , Hiperhidrosis/cirugía , Simpatectomía/métodos , Cavidad Torácica/metabolismo , Toracoscopía/métodos , Adulto , Anestesia General/métodos , Bupivacaína/administración & dosificación , Bupivacaína/uso terapéutico , Epinefrina/administración & dosificación , Epinefrina/uso terapéutico , Femenino , Humanos , Inyecciones Intralesiones/métodos , Masculino , Dimensión del Dolor/métodos , Dolor Postoperatorio/patología , Dolor Postoperatorio/prevención & control , Estudios Prospectivos , Cavidad Torácica/cirugíaRESUMEN
We report a case of acute chylous ascites secondary to acute biliary pancreatitis, the first such case reported in the literature. Surprisingly, chylous ascites was detected during elective cholecystectomy. The pathogenesis and management of this problem is discussed.
Asunto(s)
Ascitis/etiología , Quilo , Pancreatitis/complicaciones , Enfermedad Aguda , Anciano , Ascitis/metabolismo , Ascitis/cirugía , Colecistectomía , Femenino , Humanos , Pancreatitis/metabolismo , Pancreatitis/cirugía , Lavado PeritonealRESUMEN
The development of chylous ascites following abdominal surgery is an infrequent yet alarming complication. We present a patient in whom chylous ascites was diagnosed 6 days after a distal splenorenal shunt. Ten days following bed rest, sodium restriction, and a low-fat diet with medium-chain triglyceride supplementation the ascites resolved.
Asunto(s)
Ascitis Quilosa/etiología , Várices Esofágicas y Gástricas/cirugía , Hemorragia Gastrointestinal/cirugía , Cirrosis Hepática/cirugía , Complicaciones Posoperatorias/etiología , Derivación Esplenorrenal Quirúrgica , Anciano , Ascitis Quilosa/terapia , Dieta con Restricción de Grasas , Dieta Hiposódica , Femenino , Humanos , Complicaciones Posoperatorias/terapia , Triglicéridos/administración & dosificaciónRESUMEN
The use of artificial grafts was proposed to facilitate the construction of palliative bilio-enteric bypass in proximal malignant biliary obstruction. Previous reported clinical experience is favorable. We present herein our preliminary clinical and experimental experience with Dacron and PTFE (Goretex) vascular grafts for the construction of bilio-duodenal bypass. Although our clinical results appear encouraging, the use of these prosthetic conduits is not supported by experimental data obtained in dogs.
Asunto(s)
Neoplasias del Sistema Biliar/cirugía , Prótesis Vascular , Colestasis/cirugía , Cuidados Paliativos , Anciano , Animales , Neoplasias del Sistema Biliar/complicaciones , Colestasis/etiología , Perros , Resultado Fatal , Femenino , Humanos , Masculino , Persona de Mediana Edad , Tereftalatos Polietilenos , PolitetrafluoroetilenoRESUMEN
Leakage from the closed rectal stump following Hartmann's procedure appears to be more common than previously suspected. A case of a leaking Hartmann's pouch further complicated by an ileorectal communication is reported. Non-operative attempts to seal this 'spontaneous ileorectostomy' failed.
Asunto(s)
Colostomía/efectos adversos , Enfermedades del Íleon/etiología , Fístula Intestinal/etiología , Fístula Rectal/etiología , Neoplasias del Recto/cirugía , Anciano , Anciano de 80 o más Años , Humanos , Masculino , Técnicas de Sutura , Insuficiencia del TratamientoRESUMEN
Two cases of massive haemorrhage from the gallbladder in patients suffering from common bile duct obstruction are described. Sudden operative decompression of the massively distended gallbladder was the probable cause of the bleeding.
Asunto(s)
Colecistostomía/efectos adversos , Colestasis/etiología , Neoplasias del Conducto Colédoco/complicaciones , Neoplasias del Conducto Colédoco/cirugía , Descompresión Quirúrgica/efectos adversos , Enfermedades de la Vesícula Biliar/etiología , Hemorragia/etiología , Yeyunostomía/efectos adversos , Cuidados Paliativos , Neoplasias Pancreáticas/complicaciones , Neoplasias Pancreáticas/cirugía , Anciano , Colecistostomía/métodos , Descompresión Quirúrgica/métodos , Resultado Fatal , Femenino , Gastrostomía , Humanos , Yeyunostomía/métodos , Masculino , Cuidados Paliativos/métodosRESUMEN
The use of barium contrast study is considered accurate and safe in suspected intestinal obstruction. However, the use of barium in 2 patients with small-bowel obstruction converted their partial obstruction into a complete one. This complication has been previously mentioned but not documented. The use of water-soluble agents may be safer.
Asunto(s)
Sulfato de Bario/efectos adversos , Obstrucción Intestinal/complicaciones , Anciano , Humanos , Obstrucción Intestinal/diagnóstico por imagen , Masculino , Persona de Mediana Edad , RadiografíaRESUMEN
A postal survey of 283 members of the Israeli Association of Surgeons was conducted to determine their current practices as to duration of antibiotic therapy following emergency abdominal operations (response rate 26.5%). The maximal acceptable length of antibiotic administration after various emergency operations was based on recommendations in the recent literature. By these criteria, about half those responding were using excessive courses of post-operative antibiotics. We conclude that failure to distinguish between contamination, which requires either minimal post-operative administration of antibiotics or none at all, and infection which requires a proper postoperative course, is the main reason for unnecessarily prolonged postoperative use of antibiotics.
Asunto(s)
Abdomen/cirugía , Antibacterianos/uso terapéutico , Pautas de la Práctica en Medicina , Antibacterianos/administración & dosificación , Recolección de Datos , Utilización de Medicamentos , Humanos , Israel , Complicaciones Posoperatorias/tratamiento farmacológicoRESUMEN
Emergency cholecystectomy in high-risk patients is still associated with significant morbidity and mortality. Occasionally technical difficulties and bleeding diathesis are complicating factors. Our prospective experience with subtotal cholecystectomy in 23 consecutive patients is presented. All presented as increased surgical risks (APACHE II above 10) and suffered from acute cholecystitis with empyema or perforation. 1 patient died (4.4%), but overall, surgical complications were minimal. We conclude that subtotal cholecystectomy combines the advantages of cholecystectomy and cholecystostomy. We believe that this short, simple and safe procedure is a logical choice for emergency situations in critically ill patients.
Asunto(s)
Colecistectomía , Colecistitis/cirugía , Servicios Médicos de Urgencia , Adulto , Anciano , Femenino , Humanos , Complicaciones Intraoperatorias , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Factores de RiesgoRESUMEN
The incidence of isolated iliac artery aneurysm is 1-2% of that of abdominal aortic aneurysms. The natural history is of gradual enlargement, with rupture the most common clinical presentation. The signs and symptoms of such an aneurysm are influenced by its concealed location within the bony pelvis. Awareness of these special characteristics improves the chances of early diagnosis and proper surgical treatment before possible rupture. We report 2 cases which demonstrate the spectrum of the clinical presentation.
Asunto(s)
Aneurisma Ilíaco/diagnóstico , Anciano , Humanos , Masculino , Persona de Mediana EdadRESUMEN
The therapeutic effect of gastrografin is occasionally mentioned in the literature. However, this effect has not been objectively evaluated. We studied prospectively the effect of Gastrografin in cases of adhesive, simple, partial, small bowel obstruction (SBO) compared to conventional management. During 3 years, a total of 137 episodes of simple, partial SBO in 127 patients (10 recurrent episodes) were treated. The episodes were randomized into a control group (80 episodes), treated conventionally, and a trial group (77 episodes), which received in addition 100 ml of Gastrografin administered through the nasogastric tube. The two groups were well-matched with regard to age, gender, weight, medical and surgical background and duration of complaints before admission. Time to first stool and resolution of obstruction, complications, need for surgery, and hospital stay were noted. Mean time to first stool was significantly shorter in the trial group: 6.2 +/- 3.9 hours vs 23.5 +/- 12.7 (p < .0001). Mean hospital stay for unoperated patients was also shorter in the trial group: 2.7 +/- 2 days vs 5.5 +/- 2 days, (p < .0001). In addition, significantly fewer episodes in the trial group required operation, 10.4 vs 26.7% (p < 0.013). 1 patient in each group dies following operation. There were no Gastrografin-related complications and it was effective and safe for adhesive, partial, simple SBO. It significantly speeds resolution of obstruction, reduces the need for operation, and shortens convalescence.
Asunto(s)
Diatrizoato de Meglumina/uso terapéutico , Obstrucción Intestinal/terapia , Intestino Delgado , Adherencias Tisulares/terapia , Medios de Contraste , Defecación , Diatrizoato de Meglumina/administración & dosificación , Humanos , Obstrucción Intestinal/cirugía , Intubación Gastrointestinal , Tiempo de Internación , Estudios Prospectivos , Recurrencia , Adherencias Tisulares/cirugíaRESUMEN
Total colectomy and mucosal proctectomy with ileal pouch-anal anastomosis is the accepted surgical procedure for ulcerative colitis and familial polyposis of the colon. During 1981-1990, 25 patients with ulcerative colitis or familial polyposis underwent this operation in our department. In the majority a J-pouch was performed. In the early years, an 8 cm rectal muscular sleeve was left. In later cases, in accordance with opinions expressed in the medical literature, the length of the sleeve was shortened to about 3 cm. We present the functional results and the early and late complications on follow-up of up to 10 years (mean 3.5 years). Although this operation is not the ideal solution, it is better than the alternatives and is the surgical procedure of choice.
Asunto(s)
Colitis Ulcerosa/cirugía , Pólipos del Colon/cirugía , Proctocolectomía Restauradora , Adolescente , Adulto , Anastomosis Quirúrgica , Femenino , Humanos , Masculino , Persona de Mediana Edad , Complicaciones PosoperatoriasRESUMEN
Cryosurgery is an old technique which is being used for hepatic tumors as an adjuvant to hepatic resection. We recently treated 7 patients with multiple malignant liver tumors, 5 of whom had colorectal metastases, 1 carcinoid metastases, and 1 multiple hepatic lesions of hepatocellular carcinoma. 6 underwent combined liver resection and cryoablation of lesions in the remaining liver. In the 7th patient, only cryoablation was performed because hepatic resection was rejected and there was an extrahepatic metastasis. The advantages of this treatment are removal or destruction of all liver lesions found by any method, including intraoperative ultrasound examination, maximal preservation of normal liver parenchyma and that it is curative in patients inoperable by standard criteria.